Back to today’s briefing

Story perspectives

New Cancer Therapy Offers Hope for Terminal Patients

6/3/2025

44 7

Summary

Story summary

A groundbreaking cancer therapy, SYNC-T, is offering hope to terminal prostate cancer patients. In a California trial, 53% of 15 men experienced complete cancer remission through a combination of liquid nitrogen and immunotherapy. Remarkably, nine out of ten patients survived beyond 14 months, suggesting this innovative treatment could be a lifeline for advanced cases, including those similar to President Biden's.

1 of 1

Story summary

A groundbreaking cancer therapy, SYNC-T, is offering hope to terminal prostate cancer patients. In a California trial, 53% of 15 men experienced complete cancer remission through a combination of liquid nitrogen and immunotherapy. Remarkably, nine out of ten patients survived beyond 14 months, suggesting this innovative treatment could be a lifeline for advanced cases, including those similar to President Biden's.